Still, right now, with a little more than three weeks left in 2025, you may be wondering if you really should buy stocks ...

Designed with our proprietary AI-Immunology™ platform based on patient sequencing data, EVX-04 targets multiple non-conventional endogenous ...

A Frederick biotech company will unveil a new technology allowing cellular-level observation of tumors at a conference in ...

Indian biopharmaceutical company Biocon said on Saturday it would fully integrate its biosimilar unit Biocon Biologics as a wholly owned subsidiary, consolidating Biocon’s biosimilars and generics ...

A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...

A federal commission visited Stanislaus and Merced counties to learn about turning crop and other waste into new products.

RA Capital Management’s Peter Kolchinsky says the companies that survived the industry’s 2021 rout are thriving—and looking ...

As biotech firms shed jobs and life sciences funding dries up, policymakers have started to see defense technology as a way ...

Windfall Bio, a leader in methane-to-value solutions, today announced the opening of its commercial-scale demonstration facility in Houston, Texas. The demo plant showcases the company's modular ...

This is the first agreement signed by the EIB with a corporate venture capital in the healthcare sector, and is part of the EU strategy to ...

Elizabeth Holmes, the founder of Theranos, made claims regarding revolutionising blood testing through their technology, and flagship device, Edison.